Clinical Trial Update: Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating cytarabine and daunorubicin hydrochloride in adults with newly diagnosed acute myeloid leukemia; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin hydrochloride (daunorubicin hydrochloride)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2026-03-23